Fundraising FoxGenenta
3 known investors
Find your way into Genenta
Sign up to see every warm intro you have to Genenta
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Genenta team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Genenta Science is a clinical-stage biotechnology company developing Temferon, a hematopoietic stem cell-based gene therapy platform for treating cancer. The company is publicly traded on Nasdaq under the ticker GNTA.
Founders & leadership
PP
Investors · 3
CDP Venture Capitallisted by CDP Venture CapitalRoma
How we know: CDP Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Related companies · 5
TsentaTsenta automates job applications by monitoring 50,000+ career pages across major applicant tracking systems and submitting tailored, ATS-optimized applications within minutes of job postings. The platform serves active job seekers seeking to increase application volume and speed while maintaining quality application materials.
EjentaEjenta builds an agentic AI platform for connected care that delivers intelligent healthcare solutions to patient homes and manages care for members with chronic conditions like heart failure. The company partners with health plans and healthcare organizations to enable remote monitoring and intelligent care delivery.
Enanta PharmaceuticalsEnanta Pharmaceuticals is a biotechnology company that discovers and develops small-molecule therapeutics using chemistry-based research to treat diseases with high unmet medical need. Its work has contributed to hepatitis C virus combination therapies, and its pipeline includes programs in areas such as respiratory syncytial virus (RSV).
ZentalisZentalis is a biopharmaceutical company developing azenosertib and other pipeline assets, seeking strategic partnerships to advance drug development and expand market reach globally.
LeadIQLeadIQ offers a company search tool that provides B2B company profiles with data such as revenue, employee count, funding, and contact information to help sales teams find decision makers and build pipeline.
Companies working in the same space as Genenta.
Frequently asked questions
- What does Genenta do?
- Genenta Science is a clinical-stage biotechnology company developing Temferon, a hematopoietic stem cell-based gene therapy platform for treating cancer. The company is publicly traded on Nasdaq under the ticker GNTA.
- Who founded Genenta?
- Genenta was founded by Pierluigi Paracchi.
- Who are Genenta's investors?
- Genenta's investors include CDP Venture Capital, Growth Capital, Growth Engine.